Page 401 - medicina-integrativa_compress

402 PARTE II, SECCIÓN 6 TRASTORNOS METABÓLICOS Y ENDOCRINOS

11. UK Prospective Diabetes StudyGroup: Quality of life in type 2 37. McGinnis RA, McGrady A, Cox SA, et al: Biofeedback-assisted
diabetic patients is affected by complications but not by intensive relaxation in type 2 diabetes. Diabetes Care 28:2145-2149, 2005.
policies to improve blood glucose or blood pressure control 38. Ismail K, Winkley K, Rabe-Hesketh S: Systematic review and
(UKPDS 37). Diabetes Care 22:1125-1136, 1999. meta-analysis of randomized controlled trials of psychological
12. Herman W; UK Prospective Diabetes Study Group: Glycaemic interventions to improve glycaemic control in patients with type 2
control in diabetes. In Barton S(ed): Clinical Evidence, Issue 4. diabetes. Lancet 363(9421):1589-1597, 2004.
London, BMJ Publishing Group, 2000, pp 320-327. 39. Trief PM, Ploutz-Snyder R, Britton KD, et al: The relationship
13. Wagner EH, Sandhu N, Newton KM, et al: Effect of improved between marital quality and adherence to the diabetes care regimen.
glycemic control on health care costs and utilization. JAMA 285: Ann Behav Med 27:48-54, 2004.
182-189, 2001. 40. Matthews DA, Larson DB, Barry C: The Faith Factor, Volume III:
14. Murray MT, Pizzorno JE: Diabetes mellitus. In Textbook of Natural An annotated bibliography of clinical research on spiritual studies.
Medicine. Edinburgh, Churchill Livingstone, 1999, pp 1203-1204. Rockville, Md, National Institute for Healthcare Research, 1995.
15. Kostreski F: Ornish program to get national test. Fam Pract News 41. Meisenhelder JB, Chandler EN: Prayer and health outcomes in
29:1-5, 1999. church members. Alt Ther Health Med 6:56-60, 2000.
16. Esposito K, Marfella R, Ciotola M, et al: Effect of a Mediterranean- 42. Ziegler D, Ulrich H, Schatz H, et al: Effect of treatment with the
style diet on endothelial dysfunction and markers of vascular anti-oxidant alpha-lipoic acid on cardiac autonomic neuropathy in
inflammation in the metabolic syndrome: A randomized trial. patients with NIDDM. Diabetes Care 20:369-373, 1997.
JAMA 292:1440-1446, 2004. 43. Ziegler D, Nowak H, Kempler P, et al: Treatment of symptomatic
17. De Lorgeril M: Mediterranean alpha-linolenic acid rich diet, in diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a
secondary prevention of coronary heart disease. Lancet 343:1454, 1994. meta-analysis. Diab Med 21:114-121, 2004.
18. De Lorgeril M: Mediterranean dietary pattern in a randomized trial: 44. Reljanovic M, Reichel G, Rett K, et al: Treatment of diabetic
Prolonged survival and possible reduced cancer rate. Arch Intern polyneuropathy with the antioxidant thioctic acid (alpha-lipoic
Med 158:181-187, 1998. acid): A two year multicenter randomized double-blind placebo-
19. Jossa F: The Mediterranean diet in the prevention of arteriosclerosis. controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic
Recent Prog Med 87:175-181, 1996. Neuropathy. Free Radic Res 31:171-179, 1999.
20. Tapsell LC, Gillen LJ, Patch CS, et al: Including walnuts in a low- 45. Coggeshall JC: Biotin status and plasma glucose in diabetics. Ann
fat/modified-fat diet improves HDL cholesterol-to-total cholesterol N Y Acad Sci 447:389, 1985.
ratio in patients with type 2 diabetes. Diabetes Care 27:2777-2783, 46. Koutsikos D, Agroyannis B, Tzanatos-Exarchou H: Biotin for
2004. diabetic peripheral neuropathy. Biomed Pharmacother 44:511-514,
21. Jimenez-Cruz A, Bacardi-Gascon M, Turnbull WH, et al: A flexible, 1990.
low glycemic index Mexican-style diet in overweight and obese 47. Albarracin C, Fuqua B, Finch M, et al: Glycemic control is improved
subjects with type 2 diabetes improves metabolic parameters during by the combination of chromium picolinate and biotin in type 2
a 6-week treatment period. Diabetes Care 26:1967-1970, 2003. diabetes mellitus. Paper presented at American Diabetes Association
22. Koivisto VA, Kyki-Jarvinen H: Fructose and insulin sensitivity in 64th Annual Meeting, June, 2004, Orlando, Florida.
patients with type 2 diabetes. J Intern Med 233:145-153, 1993. 48. Baez-Saldana A, Zendejas-Ruiz I, Revilla-Monsalve C, et al: Effects
23. Sharma KK, Gupta RK, Gupta S, et al: Antihyperglycemic effect of of biotin on pyruvate carboxylase, acetyl-CoA carboxylase,
onion: Effect on fasting blood sugar and induced hyperglycemia in propionyl-CoA carboxylase, and markers for glucose and lipid
man. Ind J Med Res 65:422-429, 1977. homeostasis in type 2 diabetic patients and nondiabetic subjects.
24. Sheela CG, Augusti KT: Antidiabetic effects of S-allyl cysteine Am J Clin Nutr 79:238-243, 2004.
sulphoxide isolated from garlic (Allium sativum). Ind J Exp Biol 49. Debourdeau PM, Djezzar S, Estival JL, et al: Life-threatening
192:523-526, 1992. eosinophilic pleuropericardial effusion related to vitamins B 5 and H.
25. McKenna DJ, Hughes K, Jones K: Green tea monograph. Altern Ann Pharmacother 35:424-426, 2001.
Ther 6:61-82, 2000. 50. Geohas J, Finch M, Juturu V, et al: Improvement in fasting blood
26. Van Dam RM, Hu FB: Coffee consumption and risk of type 2 glucose with the combination of chromium picolinate and biotin in
diabetes: A systematic review. JAMA 294:97-104, 2005. type 2 diabetes mellitus. Paper presented at American Diabetes
27. Ardell D: Wellness Promotion. Presented at 34th Annual University Association 64th Annual Meeting, June, 2004, Orlando, Florida.
of Texas Medical Branch Family Practice Review Course, May 7-8, 51. Anderson R, Cheng N, Bryden N, et al: Beneficial effect of
2000, Galveston, Texas. chromium for people with type II diabetes. Diabetes
28. Montori VM, Farmer A, Wolan P, et al: Completing A Systematic 45(Suppl):124A, 1996.
Review in Diabetes: The Fish Oil Supplementation in Type 2 52. Baker B: Chromium supplements tied to glucose control. Family
Diabetes Story. Rochester, Minn, Cochrane Collaboration, 1999. Practice News, July 15, 1996, p 5.
29. Montori VM, Farmer A, Wollan PC, et al: Fish oil supplementation 53. Feng J, Lin D, Cheng N: Chromium picolinate reduces insulin
in type 2 diabetes: A quantitative systematic review. Diabetes Care requirements in people with type 2 diabetes mellitus.
23:1407-1415, 2000. Paper presented at American Diabetes Association 63rd Scientific
30. Huddleson JS: Living with Heart Disease and Diabetes: Exercise Sessions, June 13-17, 2003, New Orleans.
Can Help. In Benson H, Stuart E (eds): The Wellness Book: The 54. Keen H, Payan J, Allawi J: Treatment of diabetic neuropathy with
Comprehensive Guide to Maintaining Health and Treating Stress- gamma-linolenic acid. Diabetes Care 16:8-13, 1993.
Related Illness. New York, Simon & Schuster, 1992, pp 412-420. 55. Petersen M, Pedersen H, Major-Pedersen A, et al: Effect of fish oil
31. Wallace MB, Mills BD, Browning CL: Effects of cross-training on versus corn oil supplementation on LDL and HDL subclasses in type
markers of insulin resistance/hyperinsulinemia. Med Sci Sports 2 diabetic patients. Diabetes Care 25:1704-1708, 2002.
Exerc 29:1170-1175, 1997. 56. Schmidt EB, Cyerberg J: Omega-3 fatty acids: Current status in
32. Swartz AM, Strath SJ, Bassett DR, et al: Increasing daily walking cardiovascular medicine. Drugs 47:405-424, 1994.
improves glucose tolerance in overweight women. Prev Med 37: 57. Raitt MH, E CW, Morris C, et al: fish oil supplementation and risk
356-362, 2003. of ventricular tachycardia and ventricular fibrillation in patients with
33. Malhotra V, Singh S, Singh KP, et al: Study of yoga asanas in implantable defibrillators: A randomized controlled trial. JAMA
assessment of pulmonary function in NIDDM patients. Ind J Physiol 293:2884-2891, 2005.
Pharmacol 46:313-320, 2002. 58. Lopez-Ridaura R, Willett WC, Rimm EB, et al: Magnesium intake
34. Leeseberg SL, Cole MM, Patrick LJ: Expanding the enablement and risk of type 2 diabetes in men and women. Diabetes Care
framework and testing an evaluative instrument for diabetes patient 27:134-140, 2004.
education. J Adv Nurs 35:365-372, 2001. 59. White JR, Campbell RK: Magnesium and diabetes: A review.
35. Burroughs TE: Research on social support in adolescents with Ann Pharmacother 27:775-780, 1993.
IDDM. Diabetes Educator 23:438, 1997. 60. Schnack CH: Hypomagnesaemia in type II (non-insulin dependent)
36. Stuart EM, Webster A, Wells-Federman CL: Managing stress. In diabetes mellitus. Diabetologia 35:904-905, 1992.
Benson H, Stuart E (eds): The Wellness Book: The Comprehensive 61. Dietary reference intakes for vitamin A, vitamin K, arsenic,
Guide to Maintaining Health and Treating Stress-Related Illness. boron, chromium, copper, iodine, iron, manganese, molybdenum,
New York, Simon & Schuster, 1992, pp 177-188. nickel, silicon, vanadium, and zinc: A report of the Panel on